Peroxisome Proliferator-Activated Receptors: Targets for the Treatment of Metabolic Illnesses (Review)

Molecular Medicine Reports - Greece
doi 10.3892/mmr.1.3.317
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Peroxisome-Proliferator-Activated Receptors (PPARs) Are Potential Drug Targets for Cancer Therapy

Oncotarget
Oncology
2017English

Drugs and the Peroxisome Proliferator Activated Receptors

2014English

Peroxisome Proliferator-Activated Receptors - Alpha in Chronic Inflammation - Mini-Review

International Journal of Pharmacology, Phytochemistry and Ethnomedicine
2019English

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus

Therapeutic Advances in Gastroenterology
Gastroenterology
2011English

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection

PPAR Research
Drug DiscoveryPharmacology
2009English

Self-Regulation of the Inflammatory Response by Peroxisome Proliferator-Activated Receptors

Inflammation Research
ImmunologyPharmacology
2019English

Peroxisome Proliferator-Activated Receptors (Ppars) in Health and Disease.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2002English

Emerging Role of the Peroxisome Proliferator-Activated Receptors in Hepatocellular Carcinoma

Journal of Carcinogenesis & Mutagenesis
2014English

Regulation of Peroxisome Proliferator-Activated Receptors by E6-Associated Protein

PPAR Research
Drug DiscoveryPharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy